Valhi, Inc. - VHI

VHI Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
VHI	-8.4	-15.8	-34.1	-1.8	28.4	80.7	-9.7	-7.3	-65.1	-27.5
S&P 500	-1.3	-1.9	0.1	5.7	10.7	29.1	24.8	88.0	186.1	33142.5

Compare VHI with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	VHI
name	Valhi, Inc.
price	24.13
changes percentage	-8.36
change	-2.20
day low	22.08
day high	24.22
year high	41.75
year low	12.12
market cap	682753524
price avg 50	32.85
price avg 200	21.44
exchange	NYSE
volume	105708
avg volume	29890
open	23.29
previous close	26.33
eps	3.09
pe	7.81
earnings announcement	2025-03-05T10:00:00.000+0000
shares outstanding	28294800
timestamp	2024-11-15 21:00:01

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 29.7%

Overall Quarterly Financial Health: 24.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000059255
revenue	1921700000	2222500000	-13.53
gross profit	245200000	490400000	-50.00
gross profit ratio	0.13	0.22	-42.17
research and development expenses	18000000	16000000	12.50
operating expenses	277400000	317900000	-12.74
interest income	21000000	10400000	101.92
interest expense	28300000	27900000	1.43
ebitda	62900000	256300000	-75.46
ebitdaratio	0.03	0.09	-63.22
operating income	-19500000	139300000	-114.00
operating income ratio	-0.01	0.06	-116.19
net income	-12100000	136100000	-108.89
net income ratio	-0.01	0.06	-110.28
eps	-0.42	4.78	-108.79

Overall Score of Annual Income Statement

0.38 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 1,922 million in 2023 from 2,222 million in 2022 representing a change of -13.53%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 245 million in 2023 from 490 million in 2022 representing a change of -50.0%. This indicates a sales profitability decline, which is a negative sign for the company.

  Operating Income: Operating income decreased to -20 million in 2023 from 139 million in 2022 representing a change of -114.0%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to -12 million in 2023 from 136 million in 2022 representing a change of -108.89%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to -0.42 in 2023 from -0.42 in 2022 representing a change of -108.79%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  Research and Development (R&D) Expenses: R&D Expenses increased to 18 million in 2023 from 16 million in 2022 representing a change of 12.5%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Expenses: Operating Expenses decreased to 277 million in 2023 from 318 million in 2022 representing a change of -12.74%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 63 million in 2023 from 256 million in 2022 representing a change of -75.46%. The increase in EBITDA indicates improved operational efficiency and profitability.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000059255
revenue	533600000	559700000	-4.66
gross profit	116300000	121300000	-4.12
gross profit ratio	0.22	0.22	0.57
research and development expenses	0	0	NaN
operating expenses	74200000	72100000	2.91
interest income	0	0	NaN
interest expense	13400000	11900000	12.61
ebitda	42100000	69100000	-39.07
ebitdaratio	0.08	0.12	-36.09
operating income	42100000	49200000	-14.43
operating income ratio	0.08	0.09	-10.25
net income	57500000	19900000	188.94
net income ratio	0.11	0.04	203.08
eps	2.02	0.7	188.57

Overall Score of Quarterly Income Statement

0.29 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 534 million in 2024Q3 from 560 million in 2024Q2 representing a change of -4.66%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 116 million in 2024Q3 from 121 million in 2024Q2 representing a change of -4.12%. This indicates a sales profitability decline, which is a negative sign for the company.

  Operating Expenses: Operating Expenses increased to 74 million in 2024Q3 from 72 million in 2024Q2 representing a change of 2.91%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 42 million in 2024Q3 from 69 million in 2024Q2 representing a change of -39.07%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 42 million in 2024Q3 from 49 million in 2024Q2 representing a change of -14.43%. The decrease in operating income indicates worse operational performance and decreased profitability.

• 📈 Positive Indicators

  Net Income: Net income increased to 58 million in 2024Q3 from 20 million in 2024Q2 representing a change of 188.94%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 2.02 in 2024Q3 from 2.02 in 2024Q2 representing a change of 188.57%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000059255
total assets	2737000000	2835700000	-3.48
total liabilities	1475500000	1528900000	-3.49
total equity	1261500000	1306800000	-3.47
cash and cash equivalents	429600000	478500000	-10.22
short term investments	56100000	75100000	-25.30
long term investments	230700000	114100000	102.19
total current assets	1475400000	1589500000	-7.18
total non current assets	1261600000	1246200000	1.24
total current liabilities	507100000	492800000	2.90
total non current liabilities	968400000	1036100000	-6.53
common stock	300000	300000	0.00
retained earnings	461100000	482300000	-4.40
total debt	569000000	580700000	-2.01

Overall Score of Annual Balance Sheet

0.22 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 2,737 million in 2023 from 2,836 million in 2022 representing a change of -3.48%. Suggesting a decrease in asset holdings.

  Total Equity: Total Equity decreased to 1,262 million in 2023 from 1,307 million in 2022 representing a change of -3.47%. This indicates a decrease in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 430 million in 2023 from 478 million in 2022 representing a change of -10.22%. This indicates a decrease in available liquid assets.

  Short Term Investments: Short Term Investments decreased to 56 million in 2023 from 75 million in 2022 representing a change of -25.3%. This indicates a decrease in short-term investment holdings.

  Total Current Assets: Total Current Assets decreased to 1,475 million in 2023 from 1,590 million in 2022 representing a change of -7.18%. This indicates a worsen liquidity position.

  Total Current Liabilities: Total Current Liabilities increased to 507 million in 2023 from 493 million in 2022 representing a change of 2.9%. This indicates a higher short-term debt burden.

  Retained Earnings: Retained Earnings decreased to 461 million in 2023 from 482 million in 2022 representing a change of -4.4%. This indicates an accumulated losses.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 1,476 million in 2023 from 1,529 million in 2022 representing a change of -3.49%. This indicates a decrease in overall liabilities.

  Total Debt: Total Debt decreased to 569 million in 2023 from 581 million in 2022 representing a change of -2.01%. This indicates a reduction in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000059255
total assets	40400000	2533400000	-98.41
total liabilities	1420600000	1246400000	13.98
total equity	1366600000	1287000000	6.18
cash and cash equivalents	314600000	395000000	-20.35
short term investments	2100000	13800000	-84.78
long term investments	5300000	219000000	-97.58
total current assets	1406000000	1323800000	6.21
total non current assets	40400000	1209600000	-96.66
total current liabilities	503700000	378800000	32.97
total non current liabilities	916900000	867600000	5.68
common stock	300000	300000	0.00
retained earnings	554200000	499000000	11.06
total debt	611300000	520000000	17.56

Overall Score of Quarterly Balance Sheet

0.33 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 40 million in 2024Q3 from 2,533 million in 2024Q2 representing a change of -98.41%. Suggesting a decrease in asset holdings.

  Total Liabilities: Total Liabilities increased to 1,421 million in 2024Q3 from 1,246 million in 2024Q2 representing a change of 13.98%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 315 million in 2024Q3 from 395 million in 2024Q2 representing a change of -20.35%. This indicates a decrease in available liquid assets.

  Short Term Investments: Short Term Investments decreased to 2 million in 2024Q3 from 14 million in 2024Q2 representing a change of -84.78%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 504 million in 2024Q3 from 379 million in 2024Q2 representing a change of 32.97%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 611 million in 2024Q3 from 520 million in 2024Q2 representing a change of 17.56%. This indicates an increase in overall debt burden.

• 📈 Positive Indicators

  Total Equity: Total Equity increased to 1,367 million in 2024Q3 from 1,287 million in 2024Q2 representing a change of 6.18%. This indicates an increase in shareholders' equity.

  Total Current Assets: Total Current Assets increased to 1,406 million in 2024Q3 from 1,324 million in 2024Q2 representing a change of 6.21%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 554 million in 2024Q3 from 499 million in 2024Q2 representing a change of 11.06%. This indicates an accumulated profits.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000059255
net change in cash	-100000000	-230900000	56.69
operating cash flow	3900000	34900000	-88.83
free cash flow	-44600000	-32700000	-36.39
capital expenditure	-48500000	-67600000	28.25
depreciation and amortization	54100000	58500000	-7.52
deferred income tax	-48100000	600000	-8,116.67
stock based compensation	0	0	NaN
accounts payables	11200000	3900000	187.18
inventory	56700000	-204200000	127.77
acquisitions net	-1700000	-8600000	80.23
investments in property plant and equipment	-48500000	-67600000	28.25
net cash used for investing activites	-29000000	-146700000	80.23
debt repayment	-29800000	-62000000	51.94
common stock issued	0	0	NaN
common stock repurchased	-2900000	-4000000	27.50
dividends paid	-9100000	-9000000	-1.11
net cash used provided by financing activities	-75900000	-114000000	33.42
cash at end of period	462000000	562000000	-17.79
accounts receivables	-44600000	81100000	-154.99
cash at beginning of period	562000000	792900000	-29.12

Overall Score of Annual Cashflow Statement

0.29 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to -100 million in 2023 from -231 million in 2022 representing a change of 56.69%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Accounts Receivables: Accounts Receivables decreased to -45 million in 2023 from 81 million in 2022 representing a change of -154.99%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 4 million in 2023 from 35 million in 2022 representing a change of -88.83%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to -45 million in 2023 from -33 million in 2022 representing a change of -36.39%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to -48 million in 2023 from -68 million in 2022 representing a change of 28.25%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Payables: The absolute value of Accounts Payables increased to 11 million in 2023 from 4 million in 2022 representing a change of 187.18%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Dividends Paid: Dividends Paid decreased to -9 million in 2023 from -9 million in 2022 representing a change of -1.11%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000059255
operating cash flow	13500000	33500000	-59.70
free cash flow	3900000	29700000	-86.87
capital expenditure	-9600000	-3800000	-152.63
depreciation and amortization	18800000	19900000	-5.53
deferred income tax	24000000	-3900000	715.38
stock based compensation	0	0	NaN
accounts receivables	11500000	-19800000	158.08
accounts payables	19700000	-4800000	510.42
inventory	-7000000	24700000	-128.34
acquisitions net	-156800000	0	NaN
investments in property plant and equipment	-9600000	-3800000	-152.63
net cash used for investing activites	-151600000	14500000	-1,145.52
debt repayment	0	-10500000	100.00
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-2300000	-2200000	-4.55
net cash used provided by financing activities	71300000	-21200000	436.32
net change in cash	-66600000	27700000	-340.43
cash at end of period	328400000	395000000	-16.86
cash at beginning of period	395000000	367300000	7.54

Overall Score of Quarterly Cashflow Statement

0.12 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -67 million in 2024Q3 from 28 million in 2024Q2 representing a change of -340.43%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow decreased to 14 million in 2024Q3 from 34 million in 2024Q2 representing a change of -59.7%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 4 million in 2024Q3 from 30 million in 2024Q2 representing a change of -86.87%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Deferred Income Tax: Deferred Income Tax increased to 24 million in 2024Q3 from -4 million in 2024Q2 representing a change of 715.38%. This indicates that the company's tax liability for future periods has increased.

  Accounts Payables: The absolute value of Accounts Payables increased to 20 million in 2024Q3 from 5 million in 2024Q2 representing a change of 510.42%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables increased to 12 in 2024Q3 from -20 million in 2024Q2 representing a change of 158.08%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -2 million in 2024Q3 from -2 million in 2024Q2 representing a change of -4.55%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• 📈 Positive Indicators

  Capital Expenditure: Capital Expenditure decreased to -10 million in 2024Q3 from -4 million in 2024Q2 representing a change of -152.63%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	67.43	77.98	-13.53
net income per share	-0.42	4.78	-108.89
operating cash flow per share	0.14	1.22	-88.83
free cash flow per share	-1.56	-1.15	-36.39
cash per share	17.04	19.42	-12.27
book value per share	44.26	45.85	-3.47
tangible book value per share	30.94	32.53	-4.89
shareholders equity per share	32.84	33.64	-2.38
interest debt per share	20.17	20.61	-2.15
market cap	432915000	627000000	-30.95
enterprise value	572315000	729200000	-21.51
pe ratio	-35.78	4.61	-876.62
price to sales ratio	0.23	0.28	-20.15
pocfratio	111.0	17.97	517.87
pfcf ratio	-9.71	-19.17	49.38
pb ratio	0.46	0.65	-29.27
ptb ratio	0.46	0.65	-29.27
ev to sales	0.3	0.33	-9.23
enterprise value over ebitda	9.1	2.85	219.81
ev to operating cash flow	146.75	20.89	602.34
ev to free cash flow	-12.83	-22.3	42.46
earnings yield	-0.03	0.22	-112.88
free cash flow yield	-0.1	-0.05	-97.54
debt to equity	0.58	0.58	0.06
debt to assets	0.2	0.2	1.20
net debt to ebitda	2.22	0.4	455.79
current ratio	2.91	3.23	-9.80
interest coverage	-0.69	4.99	-113.80
income quality	-0.32	0.26	-225.69
dividend yield	0.02	0.01	46.44
payout ratio	-0.75	0.07	-1,237.29
sales general and administrative to revenue	0.15	0.14	5.21
research and ddevelopement to revenue	0.01	0.01	30.11
intangibles to total assets	0.14	0.13	3.61
capex to operating cash flow	12.44	1.94	542.03
capex to revenue	0.03	0.03	-17.02
capex to depreciation	0.9	1.16	-22.42
stock based compensation to revenue	0	0	NaN
graham number	17.71	60.12	-70.54
roic	0.0	0.07	-97.34
return on tangible assets	-0.01	0.06	-109.26
graham net net	-15.31	-15.56	1.58
working capital	968300000	1096700000	-11.71
tangible asset value	881800000	927100000	-4.89
net current asset value	-100000	60600000	-100.17
invested capital	1907400000	2021700000	-5.65
average receivables	311150000	342800000	-9.23
average payables	229000000	176050000	30.08
average inventory	618450000	549750000	12.50
days sales outstanding	64.65	46.3	39.65
days payables outstanding	56.3	42.02	33.99
days of inventory on hand	129.78	135.03	-3.89
receivables turnover	5.65	7.88	-28.39
payables turnover	6.48	8.69	-25.37
inventory turnover	2.81	2.7	4.05
roe	-0.01	0.14	-109.11
capex per share	1.7	2.37	-28.25

• Negative

  ROE: Return on Equity (ROE) decreased to -0.01 on 2023-12-31 from 0.14 on 2022-12-31, representing a change of -109.11%. Suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -35.78 on 2023-12-31 from 4.61 on 2022-12-31, representing a change of -876.62%. Indicating a decrease in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 2.91 on 2023-12-31 from 3.23 on 2022-12-31, representing a change of -9.80%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

• Positive

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.58 on 2023-12-31 from 0.58 on 2022-12-31, representing a change of 0.06%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
VHI
calendar year	2024	2024	NaN
revenue per share	18.72	19.64	-4.66
net income per share	2.02	0.7	188.94
operating cash flow per share	0.47	1.18	-59.70
free cash flow per share	0.14	1.04	-86.87
cash per share	11.11	14.34	-22.53
book value per share	-48.43	45.16	-207.24
tangible book value per share	-61.84	31.84	-294.26
shareholders equity per share	35.88	33.78	6.22
interest debt per share	21.92	17.9	22.47
market cap	951045000.0	495330000	92.00
enterprise value	1247745000	620330000	101.14
pe ratio	4.13	6.22	-33.55
price to sales ratio	1.78	0.88	101.39
pocfratio	70.45	14.79	376.45
pfcf ratio	243.86	16.68	1,362.17
pb ratio	0.93	0.51	80.75
ptb ratio	0.93	0.51	80.75
ev to sales	2.34	1.11	110.98
enterprise value over ebitda	29.64	8.98	230.14
ev to operating cash flow	92.43	18.52	399.13
ev to free cash flow	319.93	20.89	1,431.77
earnings yield	0.06	0.04	50.49
free cash flow yield	0.0	0.06	-93.16
debt to equity	0.6	0.52	15.51
debt to assets	15.13	0.2	7,594.37
net debt to ebitda	7.05	1.81	289.59
current ratio	2.79	3.49	-20.13
interest coverage	3.14	4.13	-24.01
income quality	0.13	1.68	-92.08
dividend yield	0.0	0.0	-45.55
payout ratio	0.04	0.11	-63.82
sales general and administrative to revenue	0.14	0.13	3.92
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	9.46	0.15	6,213.73
capex to operating cash flow	0.71	0.11	526.90
capex to revenue	0.02	0.01	164.99
capex to depreciation	0.51	0.19	167.41
stock based compensation to revenue	0	0	NaN
graham number	40.36	23.04	75.19
roic	0.02	0.03	-30.85
return on tangible assets	-0.17	0.01	-1,920.12
graham net net	-18.22	-10.59	-72.08
working capital	902300000	945000000	-4.52
tangible asset value	-1762500000	907300000	-294.26
net current asset value	-14600000	77400000	-118.86
invested capital	1284600000	1838999999	-30.15
average receivables	396150000	387700000	2.18
average payables	151400000	145300000	4.20
average inventory	526400000	489750000	7.48
days sales outstanding	66.57	63.93	4.13
days payables outstanding	35.28	28.58	23.47
days of inventory on hand	124.53	97.6	27.60
receivables turnover	1.35	1.41	-3.96
payables turnover	2.55	3.15	-19.01
inventory turnover	0.72	0.92	-21.63
roe	0.06	0.02	172.02
capex per share	0.34	0.13	152.63

• ROE:

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 4.13 on 2024-09-30 Q3 from 6.22 on 2024-06-30 Q2, representing a change of -33.55%. Indicating a decrease in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 2.79 on 2024-09-30 Q3 from 3.49 on 2024-06-30 Q2, representing a change of -20.13%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.60 on 2024-09-30 Q3 from 0.52 on 2024-06-30 Q2, representing a change of 15.51%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Positive Sentiment: Discounted Cash Flow value is 44.47 which is higher than current price 24.13, indicates the company may be undervalued.